Neurogene (NGNE) Institutional Ownership $22.64 +0.56 (+2.54%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$98.12MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$11.66M Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NGNE Institutional Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.7,050$296K0.0%N/A0.047% 11/19/2024 Barclays PLC14,859$623K0.0%+319.4%0.114% 11/16/2024 Geode Capital Management LLC220,599$9.26M0.0%-0.7%1.698% 11/15/2024 Barclays PLC14,859$623K0.0%+319.4%0.114% 11/15/2024 Jane Street Group LLC7,717$324K0.0%N/A0.059% 11/15/2024 Wellington Management Group LLP18,290$767K0.0%N/A0.141% Get the Latest News and Ratings for NGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp246,540$10.35M0.0%+17.5%1.898% 11/15/2024 RTW Investments LP1,135,256$47.64M0.7%+6.0%8.739% 11/15/2024 Redmile Group LLC964,347$40.46M2.4%-4.9%7.424% 11/15/2024 Janus Henderson Group PLC709,469$29.78M0.0%-15.0%5.462% 11/14/2024 Walleye Capital LLC44,500$1.87M0.0%-51.9%0.343% 11/14/2024 MetLife Investment Management LLC6,054$254K0.0%N/A0.047% 11/13/2024 BNP Paribas Financial Markets2,170$91K0.0%+192.8%0.017% 11/13/2024 FMR LLC731,801$30.71M0.0%+912.4%5.634% 11/12/2024 Charles Schwab Investment Management Inc.30,317$1.27M0.0%+2.5%0.233% 11/8/2024 Jennison Associates LLC78,650$3.30M0.0%N/A0.605% 11/7/2024 Quest Partners LLC1,279$54K0.0%-16.0%0.010% 10/3/2024 SG Americas Securities LLC3,576$150K0.0%N/A0.028% 8/16/2024 Driehaus Capital Management LLC102,187$3.72M0.0%+123.8%0.787% 8/14/2024 Marshall Wace LLP41,447$1.51M0.0%+37.2%0.319% 8/14/2024 Integral Health Asset Management LLC70,000$2.55M0.2%N/A0.539% 8/14/2024 Avoro Capital Advisors LLC22,029$802K0.0%N/A0.170% 8/9/2024 Renaissance Technologies LLC52,807$1.92M0.0%-10.0%0.407% 8/6/2024 Quest Partners LLC1,523$55K0.0%N/A0.012% 8/1/2024 Rhumbline Advisers13,489$491K0.0%N/A0.104% 7/26/2024 Bank of New York Mellon Corp30,428$1.11M0.0%N/A0.234% 5/16/2024 Janus Henderson Group PLC813,353$41.37M0.0%-3.4%6.266% 5/16/2024 Redmile Group LLC935,252$47.60M1.7%-1.2%7.205% 5/15/2024 Baker BROS. Advisors LP456,015$23.21M0.3%+0.6%3.513% 5/10/2024 Vanguard Group Inc.507,483$25.83M0.0%+906.5%3.943% 5/7/2024 SG Americas Securities LLC2,348$120K0.0%N/A0.018% 4/30/2024 Privium Fund Management UK Ltd5,860$274K0.1%N/A0.046% 2/15/2024 Great Point Partners LLC994,229$19.27M3.3%N/A42.326% 2/14/2024 Avidity Partners Management LP466,243$9.04M0.3%N/A19.840% 2/2/2024 BML Capital Management LLC24,666$478K0.4%N/A1.050% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, 30 institutional investors and hedge funds held shares of Neurogene. The most heavily invested institutionals were RTW Investments LP ($47.64M), Redmile Group LLC ($40.46M), FMR LLC ($30.71M), Janus Henderson Group PLC ($29.78M), Vanguard Group Inc. ($25.83M), Baker BROS. Advisors LP ($23.21M), and Great Point Partners LLC ($19.27M).Learn more on NGNE's institutional investors. What percentage of Neurogene stock is owned by institutional investors? 52.37% of Neurogene stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene stock? Of the 25 institutional investors that purchased Neurogene stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Great Point Partners LLC ($994.23K), FMR LLC ($659.52K), Avidity Partners Management LP ($466.24K), Vanguard Group Inc. ($457.06K), Jennison Associates LLC ($78.65K), Integral Health Asset Management LLC ($70K), and RTW Investments LP ($64.69K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 3,065,170 shares in the last 24 months. This purchase volume represents approximately $98.12M in transactions. Which Neurogene major shareholders have been selling company stock? The following institutional investors have sold Neurogene stock in the last 24 months: Janus Henderson Group PLC ($153.66K), Redmile Group LLC ($60.96K), Walleye Capital LLC ($48K), Renaissance Technologies LLC ($5.90K), Geode Capital Management LLC ($1.46K), and Quest Partners LLC ($244.00). How much institutional selling is happening at Neurogene? Institutional investors have sold a total of 270,225 shares in the last 24 months. This volume of shares sold represents approximately $11.66M in transactions. Related Companies MESO Major Shareholders TVTX Major Shareholders NTLA Major Shareholders PRAX Major Shareholders ARVN Major Shareholders DAWN Major Shareholders ARDX Major Shareholders SYRE Major Shareholders CALT Major Shareholders SNDX Major Shareholders This page (NASDAQ:NGNE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
